Yao Ke Selected Research

Yao Ke Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2021
4	Rheumatoid Arthritis 05/2021 - 09/2010
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 12/2018
2	Infections 02/2024 - 05/2021
2	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 04/2022
1	COVID-19 02/2024
1	Musculoskeletal Diseases (Musculoskeletal Disease) 02/2024
1	Nasopharyngeal Carcinoma 12/2023
1	Dermatitis 11/2023
1	Skin Diseases (Skin Disease) 11/2023
1	Inflammation (Inflammations) 11/2023
1	Carcinogenesis 01/2023
1	Squamous Cell Carcinoma of Head and Neck 04/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022
1	Dermatomyositis (Dermatopolymyositis) 02/2022
1	Lung Injury 02/2022
1	Stomatitis 01/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Stomach Ulcer (Gastric Ulcer) 05/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 10/2020
1	Presbyopia 01/2020
1	Cataract (Cataracts) 01/2020
1	Blister (Bulla) 01/2018
1	Bullous Pemphigoid (Pemphigoid) 01/2018
1	Atherosclerosis 01/2018
1	Oral Lichen Planus 11/2017
1	Rheumatic Diseases (Rheumatism) 05/2016
1	Ankylosing Spondylitis 09/2010

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 12/2018
2	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
2	ChemokinesIBA 01/2019 - 11/2017
1	Immunoglobulin G (IgG)IBA 02/2024
1	AntibodiesIBA 02/2024
1	garcinone EIBA 12/2023
1	interleukin-22 receptor (IL-22R)IBA 11/2023
1	Imiquimod (Aldara)FDA LinkGeneric 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	CarcinogensIBA 01/2023
1	SB 225002IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	Interleukin-8B ReceptorsIBA 01/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Vascular Endothelial Growth Factor CIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	IFIH1 Interferon-Induced HelicaseIBA 02/2022
1	tat Gene Products (tat Protein)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	iguratimodIBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Histones (Histone)IBA 10/2020
1	Lysine (L-Lysine)FDA Link 10/2020
1	Fluconazole (Zonal)FDA LinkGeneric 01/2020
1	Peptides (Polypeptides)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2018
1	Keratin-17 (Keratin 17)IBA 12/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	CD100 antigenIBA 01/2018
1	DisintegrinsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	ElementsIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 05/2016
1	HaptoglobinsIBA 05/2016
1	amsonic acid (DAS)IBA 05/2016
1	EnzymesIBA 09/2010
1	lei gong tengIBA 09/2010

Therapy/Procedure

3	Therapeutics 11/2023 - 05/2016
1	Immunotherapy 04/2022
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Multifocal Intraocular Lenses 01/2020
1	Intraocular Lenses (Intraocular Lens) 01/2020